Stop Gas Station Heroin Coalition Applauds Senate Appropriators for Closing Hemp Loophole
The Stop Gas Station Heroin coalition today commended the U.S. Senate Committee on Appropriations for unanimously approving the Fiscal Year 2026 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act.
This Senate funding bill and its House counterpart, approved in committee last month, show bipartisan support for closing the unregulated, intoxicating hemp loophole — correcting a legal gray area created by the 2018 Farm Bill and slowing the spread of Gas Station Heroin in American communities.
' Gas Station Heroin " refers to a range of foreign lab-made synthetic substances that include tianeptine, nitrous oxide, semi-synthetic and synthetic alkaloid products, and intoxicating hemp products such as Delta-8, Delta-9, Delta-10, and HHC. At issue here is this latter category of intoxicating hemp and its legal definition.
According to the 2018 Farm Bill, the federal government classifies hemp as cannabis and its derivatives with no more than 0.3% Delta-9 tetrahydrocannabinol (THC) on a dry weight basis. Delta-9-THC is the primary psychoactive compound in cannabis, responsible for the euphoric high associated with marijuana use.
Critically, the Senate funding bill would decrease the delta-9-THC limit for hemp-derived products to zero. The government's current definition of hemp permits the manufacture and distribution of products containing non-delta-9 intoxicating cannabinoids — including delta-8, delta-10, and HHC — as long as their delta-9 content remains below the statutory threshold.
The narrow standards of the 2018 Farm Bill have resulted in a regulatory loophole exploited by manufacturers and retailers of intoxicating, hemp-derived products sold in convenience stores, gas stations, and smoke shops across the country.
These chemically altered, highly concentrated products are concocted with imported extracts from overseas labs and rake in significant revenue for the international Gas Station Heroin syndicate, a multi-billion-dollar enterprise exploiting legal loopholes to drive addiction and profit while endangering Americans.
The Senate funding bill restores the original intent of the 2018 Farm Bill, which was never meant to create a loophole for synthetic THC, while protecting legitimate hemp farmers from rogue actors flooding the market with lab-made Gas Station Heroin.
Moreover, the bill would mark the most consequential federal intervention in cannabinoid policy in years, preempting and superseding a growing patchwork of state laws by establishing a uniform federal prohibition on synthetically manipulated and intoxicating hemp derivatives.
This important legislation underscores that natural botanicals are not the same as harmful synthetic substances. Although whole plant products have been used safely for centuries, bad actors are now isolating basic compounds from plants and chemically altering them in labs to create hyper-potent drugs that are poisoning consumers.
Stop Gas Station Heroin applauds Chair of the Senate Appropriations Committee Susan Collins, Chair of the Appropriations Agriculture Subcommittee John Hoeven, and Senator Mitch McConnell for their leadership in combating the Gas Station Heroin crisis by seeking to close the hemp loophole.
About Stop Gas Station Heroin
Stop Gas Station Heroin is a national coalition that aims to educate consumers about harmful synthetic drugs and advocate for smart regulation that distinguishes between legitimate, natural botanicals and dangerous, synthetic drugs, combined with enforcement of current federal laws around unapproved drugs. To learn more, navigate to stopgasstationheroin.com.
Media Contact
Colby Wilson
[email protected]
###
SOURCE: Stop Gas Station Heroin
Copyright 2025 EZ Newswire
https://app.eznewswire.com/news/stop-gas-station-heroin-coalition-applauds-senate-hemp-loophole-closure
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Thermo Fisher beats quarterly estimates on resilient demand for its tools and services
(Reuters) -Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies. Shares of the medical equipment maker were up 2.5% in premarket trading. The company joins peers such as Danaher in beating quarterly profit estimates, citing strong demand from the industry for tools and services used to make vaccines and therapies. Danaher said on Tuesday it is seeing a robust number of clinical trials and therapies under development, with steady demand from its pharmaceutical clients. On an adjusted basis, Thermo Fisher reported a profit of $5.36 per share for the quarter ended June 28, beating analysts' estimate of $5.22 per share, as per data compiled by LSEG. The company said its business strategy called "practical process improvement" is helping adjust its supply chains in the tariff environment and to actively manage its cost base. Last week, the company said it will buy French drugmaker Sanofi's New Jersey manufacturing site, "to meet growing demand from pharma and biotech customers." The Waltham Massachusetts-based company's quarterly revenue rose 3% to $10.85 billion, compared to analyst estimates of $10.68 billion. Sales at its laboratory products segment, which makes up more than half of Thermo Fisher's total sales came in at $6 billion, above estimates of $5.79 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues
(Reuters) -Shares of some highly-shorted companies, including Krispy Kreme and GoPro, jumped in premarket trading on Wednesday, aided by their names trending on social media forums a day after retail traders piled into department store company Kohl's. Doughnut chain Krispy Kreme jumped 16.1%, building on a near 27% surge on Tuesday. About 14% of Krispy Kreme's outstanding shares available for trading are shorted, according to data compiled by LSEG. Camera maker GoPro also surged about 47% to $2.01. Short interest on the stock was last at 7.7%. Another highly shorted stock - with short interest at 36.7% - was plant-based meat company Beyond Meat, whose shares jumped 10.4% on Wednesday. The growing interest in heavily shorted stocks comes after Kohl's surged 37.6% higher in volatile trading on Tuesday on the back of high retail interest. Mom-and-pop traders bought $9.64 million of its shares that day, the most by this category of investors in about three years, according to data from Vanda Research. Kohl's was flat in premarket trading on Wednesday but is the third most trending ticker on Stocktwits, a retail investor-focused social media platform. Among other highly shorted names, online gifts retailer rose 8.1%. Opendoor Technologies, which has rocketed 440% so far this month, was down 2.6% on Wednesday.

Yahoo
24 minutes ago
- Yahoo
Thermo Fisher shares climb as Q2 top and bottom line exceed estimates
-- Thermo Fisher Scientific Inc (NYSE:TMO) reported second-quarter earnings that topped expectations, with revenue also coming in ahead of forecasts. The company reported adjusted EPS of $5.36, beating the analyst estimate of $5.23. Revenue rose 3% from a year earlier to $10.85 billion, above the $10.68 billion consensus. Shares in the medical equipment maker were up 2.3% in premarket trading Wednesday as of 06:06 ET. 'Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment," said Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific. Adjusted operating income reached $2.38 billion, slightly up from $2.35 billion in the same period last year. Adjusted operating margin slipped to 21.9% from 22.3% a year ago. Related articles Thermo Fisher shares climb as Q2 top and bottom line exceed estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia If Powell goes, does Fed trust go with him?